Circulating microparticles as indicators of peripartum cardiomyopathy

Peripartum cardiomyopathy (PPCM) is associated with high mortality and morbidity. Endothelial damage involving cathepsin-D to form a 16 kDa prolactin (PRL) peptide is pathogenetically relevant. Inhibiting PRL peptide with bromocriptine has yielded promising results. We investigated whether micropart...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 2012-06, Vol.33 (12), p.1469-1479
Hauptverfasser:	WALENTA, Katrin, SCHWARZ, Viktoria, SCHIRMER, Stephan H, KINDERMANN, Ingrid, FRIEDRICH, Erik B, SOLOMAYER, Erich Franz, SLIWA, Karen, LABIDI, Saida, HILFIKER-KLEINER, Denise, BÖHM, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Analysis of Variance Biological and medical sciences Biomarkers Bromocriptine - therapeutic use Cardiology. Vascular system Cardiomyopathies - drug therapy Cardiomyopathies - pathology Case-Control Studies Cell-Derived Microparticles - pathology Female Flow Cytometry Heart Heart failure, cardiogenic pulmonary edema, cardiac enlargement Hormone Antagonists - therapeutic use Humans Medical sciences Myocarditis. Cardiomyopathies Pregnancy Puerperal Disorders - drug therapy Puerperal Disorders - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!